Sort   by:  
 Page size 
ProteomicsKILchip v1.0: A novel Plasmodium falciparum merozoite protein microarray to facilitate malaria vaccine candidate prioritization7
Passive transfer studies in humans clearly demonstrated the protective role of IgG antibodies against malaria. Identifying the precise parasite antigens that mediate immunity is essential for vaccine design, but has proved difficult. Completion of the Plasmodium falciparum genome revealed thousands ...
ORGANISM(S): Plasmodium falciparum (isolate 3D7) 
2021-02-12 | PXD011724 | Pride
Plasmodium falciparum Protein microarray Merozoite Vaccine candidates Bioinformatics Antibodies 
UnknownFeeding rates of malaria vectors from a prototype attractive sugar bait station in Western Province, Zambia: results of an entomological validation study.
Not available
S-EPMC9974387 | biostudies-literature
UnknownCharacteristics of the Western Province, Zambia, trial site for evaluation of attractive targeted sugar baits for malaria vector control.
Not available
S-EPMC11102358 | biostudies-literature
UnknownEntomological effects of attractive targeted sugar bait station deployment in Western Zambia: vector surveillance findings from a two-arm cluster randomized phase III trial.
Not available
S-EPMC11264679 | biostudies-literature
UnknownDetection of SARS-CoV-2 variant 501Y.V2 in Comoros Islands in January 2021.
Not available
S-EPMC8753575 | biostudies-literature
UnknownStatin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials.
Not available
S-EPMC7903384 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
Sort   by:  
 Page size